Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 56
Keywords: Chemotherapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Elena Parovichnikova, Vera Troitskaya, Andrey Sokolov, Olga Gavrilina, Zalina Akhmerzaeva, Larissa Kuzmina, Galina Kliasova, Julia Chabaeva, Sergey Kulikov, Sergey Bondarenko, Olga Baranova, Olga Samoilova, Kamil Kaplanov, Natalia Minaeva, Valeriy Savchenko, Russian Acute Lymphoblastic Leukemia Group
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (2): 131–139.
Published Online: 09 October 2019
... Group T-cell acute lymphoblastic leukemia (T-ALL) is a rare disease usually treated with intensive, high-dose consolidation chemotherapy followed by an allotransplant in a substantial number of patients. The data of the RALL-2009 study on 125 adult T-ALL patients suggest that similar total chemotherapy...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2019) 141 (3): 138–145.
Published Online: 15 February 2019
...Tali Siegal; Osnat Bairey Primary central nervous system (CNS) lymphoma is an aggressive brain tumor sensitive to chemotherapy and radiotherapy. Its incidence has increased in the elderly, and they account for the majority of patients. The median survival of patients older than 70 years did...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2019) 141 (2): 84–90.
Published Online: 10 January 2019
... (NHL) (i.e., B cell) represent a complex clinical challenge. Second-line, platinum-based chemotherapy followed by high-dose chemotherapy (HDT) and autologous stem cell transplantation (ASCT) improves progression-free survival (PFS) and overall survival (OS) compared to standard-dose chemotherapy alone...
Journal Articles
Eiko Hayase, Mitsutoshi Kurosawa, Hiroaki Suzuki, Kohei Kasahara, Tomohiro Yamakawa, Masakatsu Yonezumi, Sachiko Suzuki, Takanori Teshima
Journal:
Acta Haematologica
Acta Haematol (2015) 134 (2): 80–85.
Published Online: 18 April 2015
.... Chemotherapy 18 F-fluorodeoxyglucose-positron emission tomography Primary bone lymphoma Radiotherapy Primary bone lymphoma (PBL) is a rare disease. PBL comprises less than 1% of all malignant lymphomas, approximately 5% of extranodal non-Hodgkin's lymphomas and 7% of primary bone tumors [ 1 ]. PBL...
Journal Articles
Heidi Mocikova, Robert Pytlik, Pavla Stepankova, Jozef Michalka, Jana Markova, Jan Koren, Lucie Buresova, Ludek Raida, Zdenek Kral
Journal:
Acta Haematologica
Acta Haematol (2015) 134 (3): 187–192.
Published Online: 01 March 2015
... in treating NLPHL still needs clarification. Methods: We retrospectively reviewed the outcome of 23 patients with NLPHL treated with rituximab alone or in combination with chemotherapy and/or radiotherapy as part of their first- or second-line treatment. Results: The median follow-up of the whole group was 67...
Journal Articles
Claudia Schäfer, Alix O''Meara, Dimitrios A. Tsakiris, Michael Medinger, Jakob R. Passweg, Martin Stern
Journal:
Acta Haematologica
Acta Haematol (2015) 133 (3): 317–320.
Published Online: 02 December 2014
... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bleeding Chemotherapy SSRI Thrombocytopenia...
Journal Articles
Yunsuk Choi, Sung-Doo Kim, Young-Hoon Park, Jae Seok Lee, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ah Rang Jung, Je-Hwan Lee
Journal:
Acta Haematologica
Acta Haematol (2015) 133 (2): 183–192.
Published Online: 11 October 2014
... outcome is unsatisfactory. We compared up-front allogeneic hematopoietic cell transplantation (HCT) to induction chemotherapy (IC) as an initial treatment in patients with s-AML arising from MDS. This retrospective study included 85 patients who were diagnosed with s-AML arising from MDS; 11 patients...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2014) 133 (1): 89–90.
Published Online: 23 August 2014
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Acute leukemia (adult) Allogeneic bone marrow transplantation Chemotherapy Over half of adults with acute...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2014) 132 (2): 254–255.
Published Online: 05 June 2014
...Michael B. Jameson; Stephen O. Evans Chemotherapy Malignancy Radiotherapy Regardless of whether clinicians believe there is any merit to selenium (Se) supplementation in patients with malignancies, it is one of the most common supplements taken by them. The use of Se by cancer...
Journal Articles
Alexios Matikas, Alexandros Briasoulis, Ifigeneia Tzannou, Dimitra Oikonomopoulou, Maria Bakiri, Themis Karmiris, Nikolaos Harhalakis
Journal:
Acta Haematologica
Acta Haematol (2013) 130 (4): 291–296.
Published Online: 31 August 2013
... = 11, 50%) and the most common histology was diffuse large B-cell lymphoma. 21 patients received chemotherapy as initial therapy and 16 received combined chemoradiation. 81.8% of the patients (n = 18) achieved complete remission. 5-year survival rate was 86.3% and overall survival was found...
Journal Articles
Yahya Buyukasik, Kadir Acar, Engin Kelkitli, Burak Uz, Songul Serefhanoglu, Evren Ozdemir, Merve Pamukcuoglu, Hilmi Atay, Ozlen Bektas, Gulsan Turkoz Sucak, Mehmet Turgut, Salih Aksu, Munci Yagci, Nilgun Sayınalp, Osman I. Ozcebe, Hakan Goker, Ibrahim C. Haznedaroglu
Journal:
Acta Haematologica
Acta Haematol (2013) 130 (3): 199–205.
Published Online: 19 June 2013
... lymphoblastic leukemia is unsatisfactory in adults due to disease and patient-related factors and probably because adult chemotherapy regimens are weaker than pediatric protocols. Worries about inadequacy of adult regimens urged many hematologists, including us, to reconsider their routine treatment practices...
Journal Articles
Hiromi Koiso, Akihiko Yokohama, Takeki Mitsui, Takayuki Saitoh, Hiroshi Handa, Hirokazu Murakami, Junko Hirato, Masaru Kojima, Yoshihisa Nojima, Norifumi Tsukamoto
Journal:
Acta Haematologica
Acta Haematol (2012) 128 (1): 47–52.
Published Online: 17 May 2012
... marrow involvement Splenomegaly Chemotherapy Follicular lymphoma Although the spleen is frequently involved in B cell lymphomas, marked splenomegaly as a main presenting sign in follicular lymphoma (FL) is rare. Thus, FL presenting with splenomegaly as the only involvement should...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2012) 127 (2): 124–127.
Published Online: 12 January 2012
... manifestations. 29 08 2011 26 10 2011 12 1 2012 In our case, even though the tumor was highly sensitive to chemotherapy, the response duration time was short, and the disease progressed rapidly after relapse with an overall survival time of 15 months. Review of the literature illustrates...
Journal Articles
Tsutomu Kobayashi, Junya Kuroda, Hitoji Uchiyama, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki
Journal:
Acta Haematologica
Acta Haematol (2011) 127 (1): 10–15.
Published Online: 07 October 2011
.... This report concerns the effect of cyclosporin A (CsA) on chemotherapy-refractory AITL. A 68-year-old female with AITL with systemic symptoms, such as high fever, skin rash andgeneralized lymphadenopathy, was initially treated with conventional cytotoxic chemotherapies using alkylators, anthracyclines...
Journal Articles
Petr Lemež, Hana Klamová, Zuzana Zemanová, Iuri Marinov, Ota Fuchs, Jiří Schwarz, Jana Březinová, Dana Provazníková, Arnošt Kostečka, Jana Marková, Kyra Michalová, Jaroslav Jelínek
Journal:
Acta Haematologica
Acta Haematol (2011) 126 (3): 129–134.
Published Online: 24 June 2011
... myeloid leukemia Chemotherapy Diagnosis Multilineage dysplasia Polyploidy Prognosis Tetraploidy The European Group for the Immunological Characterization of Leukemias (EGIL) reported 25 patients with rarely occurring near-tetraploid acute myeloid leukemia (NT-AML). They showed...
Journal Articles
Yong Park, Yoon Ji Choi, Se Jong Park, Se Ryeon Lee, Hwa Jung Sung, Kyong Hwa Park, Soek Jin Kim, Chul Won Choi, Kwang Yoon Jung, Byung Soo Kim
Journal:
Acta Haematologica
Acta Haematol (2011) 126 (2): 79–86.
Published Online: 04 May 2011
.... We evaluated the prognostic significance of the pretreatment serum level of 15-kDa granulysin in patients with diffuse large B cell lymphoma (DLBCL). Patients and Methods: A retrospective analysis was conducted on 88 DLBCL patients treated homogeneously with standard chemotherapy. The granulysin...
Journal Articles
Francesco Gaudio, Annamaria Giordano, Tommasina Perrone, Domenico Pastore, Paola Curci, Mario Delia, Anna Napoli, Clara de’ Risi, Alessandro Spina, Rosalia Ricco, Vincenzo Liso, Giorgina Specchia
Journal:
Acta Haematologica
Acta Haematol (2011) 126 (1): 44–51.
Published Online: 24 March 2011
..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemotherapy Lymphoma Rituximab Accounting for approximately 30% of all...
Journal Articles
Lee Chun Park, Ho Sup Lee, Seong Hoon Shin, Hana Im, Byeong Jin Ye, Moo Kon Song, Sung Yong Oh, Sang Min Lee, Won Sik Lee, Yang Soo Kim
Journal:
Acta Haematologica
Acta Haematol (2011) 125 (4): 230–236.
Published Online: 12 February 2011
... transplantation or receiving chemotherapy. However, there have been few reports on the incidence and risk factors of HVIs in diffuse large B-cell lymphoma (DLBL) patients treated with rituximab combined chemotherapy. Methods: We analyzed 270 patients who were newly diagnosed with DLBL. All of the patients had...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2010) 125 (1-2): 32–38.
Published Online: 08 December 2010
... with early-stage HL compared radiotherapy alone to combined-modality treatment (CMT). It was followed in 1998 by an individual-patient meta-analysis examining the role of radiotherapy with and without chemotherapy. In 2006, a comprehensive meta-analysis focusing on the risk of secondary malignancies...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (1974) 52 (6): 349–355.
Published Online: 04 March 2009
.... Chemotherapy Hodgkin’s disease Multiple malignancies Myeloma Paraproteins Acta Haemat. 52: 349-355 (1974) Myeloma in a Case of Hodgkin s Disease J. C. C awley, A. H. G oldstone, J. A rno, J. H. K. R ees and A. G rant Departments of Medicine and Clinical Pathology, University of Cambridge, Cambridge...
1